Abstract
Introduction
SMADs, SMAD6 and SMAD7 are themselves induced by BMPs and inhibit BMP signalling 48 (19, 39) , thus providing a negative feedback loop. Alternative signalling pathways through 49 p38MAPK, JNK, and ERK activation have been documented (49), as well as activation of the 50 miRNA, miR-21, leading to the decrease of RNA targets such as dedicator of cytokinesis -51
DOCK 180 related proteins (21). 52
Few transcriptional target genes of BMPs have been identified and include Id1, Id2, TBX20 53 (32), and VEGFA (44). 54
BMPs have been shown to play an important role in vascular development and homeostasis 55 (28, 35) . Heterozygous ACVRL1 or ENG mutations cause hereditary hemorrhagic 56 telangiectasia, a severe angiodysplasia affecting capillary and large vessel formation. Mono-57 allelic BMPR2 and ACVRL1 mutations are responsible for the heritable form of pulmonary 58 hypertension, a rare and severe disorder characterized by elevated pulmonary vascular 59 resistance due to vasoconstriction and medial hypertrophy of small pulmonary arteries (36) . 60 BMPR1A (ALK3) and SMAD4 heterozygous mutations cause juvenile polyposis of the colon, 61 associated with HHT in the case of Smad4 mutations. BMP pathway genes disruptions in 62 mice have demonstrated their major roles in embryonic angiogenesis. Indeed, ACVRL1 or 63
Results

122
BMPs down-regulate apelin in microvascular endothelial cells. 123 DNA microarray experiments were performed to identify BMP target genes in HMEC-1 124 stimulated for 7 h or 24 h by 10ng/mL of BMP4. Among the modulated genes, including ID1, 125 ID2 and ID3, which were markedly up-regulated (data not shown), we observed a strong 126 down-regulation of apelin expression by BMP4 at both 7 h and 24 h of stimulation. 127
We confirmed, by real-time PCR, the down-regulation of apelin expression in HMEC-1 cells 128 treated by 10ng/mL of BMP4 (Fig. 1A) . 129
Apelin mRNA levels were also decreased by other members of the BMP family of cytokines, 130 BMP7 and BMP9, similarly to BMP4 (Fig.1A) . We found that 4h after stimulation and for at 131 least 24h, BMP7 and 9 inhibited by 60% and by up to 96% the mRNA expression of apelin, 132
respectively. Similar results were obtained with BMP10 (data not shown). 133
Apelin expression was measured in primary human lung microvascular endothelial 134 cells (HLMEC) after 24h of BMP treatment (50ng/mL). BMP4 and BMP7 inhibited apelin 135 expression by 50% whereas BMP9 inhibited apelin expression for more than 96 % (Fig. 1B) . 136
Apelin down-regulation by BMPs is mediated by BMPR2 and the SMAD 137 pathway 138
We knocked-down the expression of BMPR2 by using a BMPR2-targeting siRNA. BMP 139 down-regulation of apelin expression is strongly decreased, but not abolished, in cells 140 transfected with BMPR2-directed siRNA compared with those transfected with non-specific 141 siRNA, and with cells transfected with an ACVR2A directed siRNA ( Fig.2A) , demonstrating 142 that the down-regulation of apelin expression by BMP is mainly mediated by BMPR2. BMP 143 down-regulation of apelin expression is also decreased in cells transfected with both BMPR2 144 and ACVR2A siRNAs ( Fig.2A) , showing that there is no functional rescue between the two 145 receptors. ACVR2B siRNA did not modify BMP9 apelin mRNA down-regulation (data not 146 shown). 147
The canonic BMP signaling pathway involves SMAD phosphorylation of Receptor-Smads 148 (R-Smads) and of the co-Smad, SMAD4. SMAD4 knock-down by siRNA resulted in an 149 attenuated apelin down-regulation (Fig 2B) . The inhibitory SMAD7 competes with R-Smad 150 for the activated type I receptor binding site, and is therefore a signal transducing inhibitor. 151
We infected cells with a SMAD7 expressing adenovirus and observed a complete suppression 152 of the apelin down-regulation by BMP9, and even a slight increase in basal apelin mRNA 153 expression (Fig. 2C ). This shows that BMP9 inhibits apelin expression via the SMAD 154 pathway and that even in unstimulated conditions, the basal SMAD activity, possibly due to 155 the presence of BMP ligands in the culture medium, inhibits apelin expression. 156 157
Molecular mechanism of apelin down-regulation by BMPs 158
In order to determine which step was involved in the BMP-induced apelin down-regulation, 159 we inhibited DNA transcription or mRNA translation by pre-treating cells with actinomycin 160 D or cycloheximide, respectively, before BMP stimulation. In actinomycin D-treated cells, we 161 did not observe the down regulation of apelin expression in response to BMP, showing that 162 BMP9 does not act on the stability of the apelin mRNA (Fig. 3A) . After cycloheximide 163 treatment, BMP still induced a decrease of apelin mRNA levels, although attenuated. 164
Altogether, these results suggest that apelin inhibition by BMPs relies on a transcriptional 165 mechanism and is in a large part independent of de novo synthesized proteins. 166
We analysed the transcriptional activity of the apelin gene by measuring its pre-mRNA 167 expression by real-time PCR using primers that hybridize to sequences found in introns and, 168 therefore, specifically recognize pre-mRNA (genomic DNA was removed during RNA 169 processing to avoid binding of primers). After 5h of BMPs treatment, pre-mRNA levels were 170 strongly reduced, showing that apelin transcription is inhibited by BMP stimulation (Fig. 3B) . 171
We characterized the apelin promoter activity in response to BMP by transfecting HMEC-1 172 with luciferase reporter constructs under the control of fragments of the human apelin 173 promoter. None of the constructs tested, including one containing 2500bp of the proximal 174 promoter, responded to BMP stimulation (data not shown). We also tested the hypothesis that 175 the transcriptional down regulation of apelin by BMPs is due to the RNA degradation by a 176 microRNA. However by inhibiting the processing enzyme DROSHA with a DROSHA-177 targeting siRNA, we did not observe any difference between BMP-treated and untreated cells 178 (data not shown). Thus, BMP downregulation of apelin expression involves a transcriptional 179 step, but its precise mechanism remains elusive. 180 181
Enforced expression of Apelin restored hypoxia-induced endothelial cell proliferation 182 inhibited by BMPs 183
We performed BrdU incorporation assay in endothelial cells treated with BMP4, BMP7 and 184 BMP9, exposed or not to hypoxia (1% O2). When endothelial cells were exposed to hypoxia 185 for 24h, BrdU incorporation was significantly increased. This effect was partially abolished in 186 the presence of BMPs (Fig 4A) . Since, we demonstrated that apelin participates in hypoxia-187 induced endothelial cell proliferation (13), we hypothesized that down-regulation of apelin 188 expression by BMPs inhibits the hypoxia-induced cell proliferation. Indeed, when we over-189 expressed apelin by using an adenovirus vector we observed an increased BrDU incorporation 190 rate showing that inhibition of hypoxia-induced endothelial cell proliferation by BMPs is no 191 more detectable (Fig. 4B) . Determination of apelin expression levels revealed that hypoxia-192 induced apelin expression is reduced when cells are treated with BMPs ( Fig. 4C) . shown to promote primary miR-21 processing by acting within the DROSHA complex (10), 214 we tested the hypothesis of a microRNA mediated inhibition of apelin expression by BMP 215 using the knocking-down of DROSHA, in order to inhibit the processing of a putative 216 primary miRNA which might have decreased APLN mRNA levels. The absence of effect 217 observed with the DROSHA siRNA on apelin down-regulation by BMP does not favour this 218 hypothesis. Therefore, BMPs acts on apelin expression through the BMPR2-SMAD signaling 219 pathway on apelin transcription, but the comprehensive mechanism leading to expression 220 inhibition remains elusive. 221
Our results are at discrepancy with those of Alastalo et al who showed that BMP2 222 induces a transcriptional complex associating PPARγ and β-catenin, which in turn induces 223 APLN transcription, through BMPR2 signaling (1). Our results are difficult to reconcile with 224 these findings, although we didn't use BMP2, but we observed the APLN mRNA suppression 225 with BMP4, 7 and 9. 226
As an example of the relevance of our results in pathological conditions, we found an BMP4 were shown to be increased by hypoxia in the early phase of rat in vivo models of 236 hypoxia (41, 45), but BMP signaling is attenuated in the lung vessels during hypoxia models 237 at later stages in rat models (41). It has also been shown that BMP signaling is decreased 238 under hypoxia at the level of target genes transcription by interaction with CtBP1 in cultured 239 human pulmonary VSMC (48). BMP antagonists, such as gremlin and chordin were also 240 shown to be increased during hypoxia (6, 20) . We previously demonstrated that apelin 241 expression is increased by hypoxia (13) and we show here that this increase is partially 242 suppressed by BMP. Therefore, pathological conditions where BMP expression is increased 243 are the most likely to inhibit APLN expression, and inversely, those where BMP is decreased, 244 as during experimental and human pulmonary arterial hypertension (PAH), APLN expression 245 is likely to increase, as observed by SMAD7 inhibition in our study. 
